S. Dar
Henry Ford Health System
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. Dar.
Scientific Reports | 2017
S. Dar; J. Chhina; Ismail Mert; Dhananjay Chitale; Thomas E. Buekers; Hareena Kaur; Shailendra Giri; Adnan R. Munkarah; Ramandeep Rattan
Earlier investigations have revealed that tumor cells undergo metabolic reprogramming and mainly derive their cellular energy from aerobic glycolysis rather than oxidative phosphorylation even in the presence of oxygen. However, recent studies have shown that certain cancer cells display increased oxidative phosphorylation or high metabolically active phenotype. Cellular bioenergetic profiling of 13 established and 12 patient derived ovarian cancer cell lines revealed significant bioenergetics diversity. The bioenergetics phenotype of ovarian cancer cell lines correlated with functional phenotypes of doubling time and oxidative stress. Interestingly, chemosensitive cancer cell lines (A2780 and PEO1) displayed a glycolytic phenotype while their chemoresistant counterparts (C200 and PEO4) exhibited a high metabolically active phenotype with the ability to switch between oxidative phosphorylation or glycolysis. The chemosensitive cancer cells could not survive glucose deprivation, while the chemoresistant cells displayed adaptability. In the patient derived ovarian cancer cells, a similar correlation was observed between a high metabolically active phenotype and chemoresistance. Thus, ovarian cancer cells seem to display heterogeneity in using glycolysis or oxidative phosphorylation as an energy source. The flexibility in using different energy pathways may indicate a survival adaptation to achieve a higher ‘cellular fitness’ that may be also associated with chemoresistance.
Oncotarget | 2014
Calvin Tebbe; J. Chhina; S. Dar; Kalli Sarigiannis; Shailendra Giri; Adnan R. Munkarah; Ramandeep Rattan
Oncotarget | 2014
Z. Al-Wahab; Calvin Tebbe; J. Chhina; S. Dar; Robert T. Morris; Rouba Ali-Fehmi; Shailendra Giri; Adnan R. Munkarah; Ramandeep Rattan
Mycopathologia | 2016
Chhavi Gupta; Shukla Das; Rumpa Saha; Sambit Nath Bhattacharya; S. Dar; Dharmendra Atri
Immunotherapy | 2018
Sharif Sakr; S. Dar; Shailendra Giri; Adnan R. Munkarah; Ramandeep Rattan
Gynecologic Oncology | 2017
Ramandeep Rattan; S. Dar; Nabila Rasool; Rouba Ali-Fehmi; Shailendra Giri; Adnan R. Munkarah
Archive | 2016
Miriana Hijaz; Soumen Das; Ismail Mert; Ankur Gupta; Z. Al-Wahab; Calvin Tebbe; S. Dar; J. Chhina; Shailendra Giri; Adnan R. Munkarah; Sudipta Seal; Ramandeep Rattan
Gynecologic Oncology | 2016
Miriana Hijaz; Soumen Das; Ismail Mert; J. Chhina; Calvin Tebbe; S. Dar; Sudipta Seal; Adnan R. Munkarah; Ramandeep Rattan
Gynecologic Oncology | 2015
Ramandeep Rattan; J. Chhina; S. Dar; S. Hensley Alford; M. Deshpande; N. Rasool; Shailendra Giri; Adnan R. Munkarah
Gynecologic Oncology | 2015
Ramandeep Rattan; S. Dar; J. Chhina; M. Deshpande; Thomas E. Buekers; Shailendra Giri; Adnan R. Munkarah